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Introduction 41
Biofilm formation is a universal virulence strategy adopted by bacteria to survive 42 in hostile environments [1, 2] . The Gram-negative opportunistic pathogen Pseudomonas 43 aeruginosa is a remarkable biofilm-forming species that commonly establishes chronic 44 infections in the lungs of patients with the genetic disease Cystic Fibrosis (CF) [2, 3] . 45
Growth as a biofilm promotes multidrug resistance to antibiotic interventions and 46 evasion of immune clearance [1, 4, 5] . Biofilm formation is a conserved process of 47 attachment, maturation and dispersion, where sessile, bacterial aggregates are held 48 together by a protective polymeric extracellular matrix comprised mainly of 49 exopolysaccharides (EPS) and extracellular DNA [1, 4, [6] [7] [8] . P. aeruginosa strains 50 produce three different EPS molecules; alginate, Pel and Psl [9] . Pel and Psl are the 51 major EPS produced in the early CF colonizing, non-mucoid isolates [10, 11] , and also 52 contribute to biofilm formation in mucoid CF isolates, which overproduce alginate and 53 emerge as the infection progresses [8, 12] . 54
Both Pel and Psl have diverse roles in biofilm formation, antibiotic resistance, 55 immune evasion, and whose overproduction leads to hyperaggregative small colony 56 variants (SCVs) [1, 13] . Pel is a positively charged EPS, formed by partially acetylated 57 galactosamine and glucosamine residues, with both cell-associated and secreted forms 58 [5] . Psl is a neutrally charged EPS, comprised of repeating pentamers of D-mannose, 59 D-glucose and L-rhamnose, which can be also found as part of the bacterial capsule 60 and secreted to form the biofilm matrix [6, 14] . Both Pel and Psl are able to initiate 61 biofilm formation [1, 15] . Pel functions as an adhesin that is critical for initial cell-cell and 62 cell-surface interactions and the formation of pellicles in the air-liquid interface [1, 15] . 63
Pel also has a structural role in cross-linking eDNA, establishing the scaffold of the 64 biofilm [5] . In the Drosophila melanogaster oral feeding model, Pel is highly expressed 65 and required for biofilm formation in the fruit fly crop [16] . Mutation in the pel operon 66 results in rapid escape from the gastrointestinal tract and faster killing of D. 67 melanogaster, highlighting the function of EPS to limit dissemination in chronic fruit fly 68 infections [16] . Psl arranges in fiber-like structures that are also crucial for cell-surface 69 interactions, matrix development and biofilm architecture [1, 6, 7] . Both Pel and Psl are 70 also involved in antimicrobial resistance, where Pel is crucial for increased biofilm 71 resistance to aminoglycosides [15] and Psl contributes short-term tolerance to 72 polymyxins, aminoglycosides and fluoroquinolone antibiotics [17] . Further, Psl has also 73 been shown to reduce recognition by the innate immune system, blocking complement 74 deposition on the bacterial surface and reducing phagocytosis, release of reactive 75 oxygen species (ROS) and cell killing by neutrophils [18] . 76
Biofilms are intimately related to antibiotic tolerance and persistent infections [15, 77 19 ], therefore, there is an urgent need for the identification of new approaches that 78 target and inhibit the biofilm mode of growth for the prevention or treatment of chronic 79 bacterial infections. In order to identify new molecules effective against biofilms, high-80 throughput screening (HTS) approaches have been employed to screen large numbers 81 of compounds that reduce biofilm formation and/or detach pre-formed biofilms in many 82 species of bacteria [20] [21] [22] [23] [24] . 83
Given the importance of Pel and Psl in P. aeruginosa biofilm formation, they are 84 attractive targets for antibiofilm drug development. In this study we used a HTS gene 85 expression approach to screen a 31,096-member small-molecule drug library for 86 compounds that repress pel and psl gene expression. Consistent with our hypothesis, 87 the pel/psl repressor compounds inhibited EPS secretion and also had significant 88 antibiofilm activity. Further testing of these compounds revealed their antivirulence 89 activity in Caenorhabditis elegans infection model, and their synergy with conventional 90 antibiotics. The anti-infective compounds identified here do not inhibit bacterial growth 91 and may therefore limit the development of antibiotic resistance if developed for use as 92 novel treatments for chronic P. aeruginosa infections. 93 94
Results and Discussion 95 96
High throughput screening for repressors of EPS gene expression. A HTS for 97 compounds that repress expression from a pelB::lux reporter was performed in 384-well 98 microplate format using the Canadian Chemical Biology Network drug library containing 99 31,096 small molecule compounds. The P. aeruginosa pelB::lux reporter was grown in 100 defined BM2 medium with limiting 20 µM magnesium (Mg 2+ ), which we have identified 101 previously as a growth condition that promotes biofilm formation, due to increased 102 pel/psl expression and increased EPS production [4] . In the primary HTS screen, we 103 tested the ability of compounds at 10 µM to reduce pel gene expression. Gene 104 expression, in counts per second (CPS), was measured at a single time point (14 hours) 105 in each well of 384-well microplates and normalized to the mean gene expression of 106 each microplate. With this approach we were able to identify 163 compounds that 107 reduced pel gene expression by at least 50% ( Figure 1A) . In a secondary screen of 108 retesting the initial 163 hits, 14 compounds were identified that consistently repressed 109 pelB::lux expression by 50% or greater, without any effect on growth. We next 110 determined that the top 14 compounds also repressed a pslA-lux reporter by at least 111 50%. The structures to the 14 pel repressors are shown in Figure 2 and are described in 112 Table 1 . 113
There were an additional 26 compounds that acted as pelB::lux repressors but 114 that also had bactericidal or bacteriostatic properties (Table S2 ). These antimicrobial 115 compounds could be separated into three different groups: small molecules with known 116 antibiotic/disinfectant properties (group A), characterized non-antimicrobial molecules 117 (group B) and uncharacterized molecules (group C) (Table S2 ). The identification of this 118 panel of compounds highlights the ability of our approach to identify pel inhibitors, as 119 well as antimicrobial molecules. It is noteworthy to mention that among these 120 uncharacterized molecules (group C), two compounds (SPB07211 and KM07965) were 121 recently identified in a whole-cell based HTS for small molecules that inhibit 122 Burkholderia cenocepacia growth [25], and one small molecule (KM06346) was 123 identified in a screen for nonspecific inhibitors of DNA repair enzymes (AddAB helicase 124 nuclease) in Escherichia coli [26] . Nevertheless, all these growth inhibitor compounds 125 were removed from the study. 126
To confirm the gene repression ability of these compounds, 13 of the 14 molecules 127 (I1-I13) were reordered and retested. The 13 gene inhibitor compounds show a 30-90% 128 repression of pelB::lux reporter gene expression ( Figure 1B) , in comparison to the same 129 reporter strain cultured in biofilm inducing conditions alone. Additionally, most of the 130 compounds were also able to reduce expression of pslA-lux reporter by 10-85% ( Figure  131 1B), showing an effect over both EPS gene clusters. To determine if any of the 132 compounds had a nonspecific effect on lux (luminescence), we grew a control lux 133 reporter to the16S ribosomal RNA genes (PAO1::p16Slux) [27] in the presence of 10 134 µM compounds and measured gene expression throughout growth. There were minimal 135 effects on 16S lux expression for most of the molecules, however one compound was a 136 strong lux repressor (I3) and interestingly, one compound was a lux activator (I2) 137 ( Figure S1A ). Therefore, we repeated the gene expression experiments with the 138 pelB::lux and pslA-lux reporters and controlled for the compound effect on 139 PAO1::p16Slux, and again demonstrated that most compounds were repressors of both 140 the pel (12/13) and psl (7/13) genes, relative to their effects on 16S expression ( Figure 3B ). To better observe their antibiofilm effects in 155 different strains of P. aeruginosa, we selected three different strains that differ in their 156 ability to produce the two EPS molecules. The PA14 strain, due to a 3-gene deletion in 157 the psl cluster, is only able to produce and secrete Pel, while PAO1 is able to produce 158 both EPS molecules [10] . The majority of pel/psl repressors (11/13) promoted a 159 significant reduction in biofilm formation in PA14 ( Figure 3B ), and most were effective 160 (7/13) in reducing total biofilm biomass produced by PAO1 strain ( Figure 3B ). We also 161 tested their antibiofilm activity against the retS::lux mutant, which is known to 162 overproduce both the Pel/Psl and therefore have a hyperbioflm phenotype [30] , similar 163 to the small colony variants that arise in biofilms and in the CF lung [2] . Interestingly, 164 10/13 compounds were also effective in reducing biofilm formation in the insertional 165 mutant retS::lux strain ( Figure 3B ). We were curious to assess whether there may be 166 synergistic effects of combining the compounds; therefore, we tested the combination of 167 2 or 3 inhibitor compounds (at a total concentration of 10 µM) that we identified as 168 strong repressors of pelB::lux expression (data not shown). We observed that some 169 combinations were synergistic and resulted in greater degrees of biofilm inhibition than 170 individual compounds ( Figure S2A -C). 171
We next wanted to assess whether our compounds could inhibit the formation of 172 biofilms in continuous flow systems, which tends to better mimic natural biofilms due to 173 hydrodynamic influences [31, 32] . We cultivated and quantitated green fluorescent 174 protein (gfp)-tagged PA14 and PAO1 biofilms in the BioFlux biofilm device ( Figure 4A ). 175
We selected 9 individual antibiofilm compounds and 3 mixtures that showed strong 176 biofilm inhibition in microplates. The majority of individual compounds and the 177 combination treatments significantly reduced biofilm formation against PAO1-gfp and 178 PA14-gfp, reducing both the depth ( Figure 4B ) and total coverage ( Figure 4C ) of 179 biofilms grown in the BioFlux channel walls. Consistent with the CV biofilm assays 180 ( Figure S2 ), all compound mixtures tested had greater effects on reducing biofilms than 181 individual compounds alone ( Figure 4 ). 182
Pel/Psl repressors reduce mucoid biofilm formation and non-mucoid biofilms 184
under anaerobic conditions. It is known that the chronically infected, mucus-filled 185 airways of the CF lung lead to the selection of mucoid and alginate-overproducing P. conditions. BM2 containing 2mM Mg 2+ was used to minimize the contribution of Psl/Pel 194 production in this experiment. Six antibiofilm compounds present at 10 µM promoted a 195 modest but significant reduction in biofilm formation for the mucoid strain ( Figure 5A ). 196
Interestingly, two of the Psl/Pel antibiofilm compounds had a biofilm promoting effect on 197 the mucoid variant of PAO1 ( Figure 5A ). 198
Previous reports have shown that the CF mucus plug environment consists of both 199 aerobic and anaerobic microenvironments [37] . Therefore, we tested our compounds for 200 their ability to reduce biofilm formation under anaerobic conditions. The antibiofilm 201 compound treatments (10/13) were able to promote a significant reduction in biofilm 202 formation in the PA14 strain under anaerobic conditions, while 6/13 compounds were 203 effective against the PAO1 strain ( Figure 5B ). Importantly, 10/13 compounds also 204 reduced biofilm formation in the hyperbiofilm forming mutant retS::lux strain under 205 anaerobic conditions ( Figure 5B ). Although most of the compounds showed a similar 206 trend in biofilm repression for both aerobic and anaerobic conditions, compound I6 207 showed antibiofilm properties only under anaerobic growth. Additionally, we were 208 unable to determine biofilm inhibition by compound I11, as it was inhibiting bacteria 209 growth under anaerobic conditions for the three strains tested (data not shown). 210 211 Pel and Psl are required for PAO1 full virulence in the C. elegans infection model. 212
Although Pel and Psl are well appreciated for their role in biofilm formation, their 213 contribution to virulence is less understood. P. aeruginosa is known to colonize the 214 intestinal lumen of C. elegans and cause severe alterations in its morphology [38] . 215 Furthermore, P. aeruginosa forms clumps in the nematode gut, surrounded by an 216 uncharacterized extracellular matrix [38] . Therefore, to determine whether Pel and/or 217 Psl contribute to bacterial virulence we utilized the nematode infection model. We 218 assessed the nematode feeding preference and slow killing assays when C. elegans 219 were fed P. aeruginosa possessing mutations in the pel and psl gene clusters. Initially 220 we used the feeding preference assay, where the nematodes are given an option of test 221 strains within a grid of 48 colonies [39]. As feeding is observed until colony 222 disappearance, strains that are eaten preferentially were also shown to be less virulent 223 in the slow killing assays [39] . While single knockouts in either the pel or psl genes did 224 not alter the nematode feeding behavior, a double Δpel/psl mutant was preferentially 225 eaten by C. elegans, when given the choice of between Δpel/psl and PAO1 ( Figure 6A ). 226
As a control experiment, the laboratory food source E. coli OP50 also served as a 227 preferential food source to PAO1 ( Figure 6A ). None of the mutant strains tested in the 228 feeding preference assay showed a growth defects in SK media (data not shown). This 229 result suggests a virulence role for Pel and Psl in vivo. 230
To further investigate the role of EPS in virulence, we conducted slow killing 231 assays [39, 40] , in which nematodes are given a single bacterial food source, and 232 worms survival is monitored over 10 days. In addition to the single and double pel/psl 233 mutant panel, we also tested the Pel/Psl hyperproducing retS::lux mutant. In the slow 234 killing assay, both the single pel and psl mutants, as well as the double Δpel/psl were 235 less virulent and resulted in increased nematode survival throughout 10 days ( Figure  236 6B). Interestingly, the retS::lux mutant, known to overproduce both Pel and Psl, 237 demonstrated an increased virulence in the slow killing assay ( Figure 6B ). Although this 238 effect in the retS::lux mutant may be due to other pleiotropic effects of mutation in this 239 regulatory protein [30], taken together, these observations indicate that both the Pel and 240
Psl are required for full virulence of P. aeruginosa in killing C. elegans. 241 242 Antibiofilm molecules also have antivirulence activity. Since the Pel/Psl are 243 required for C. elegans full virulence ( Figure 6 ), we hypothesized that the antibiofilm 244 compounds identified in the HTS would also reduce virulence of the wild type PAO1. 245
For the slow killing assay, PAO1 was inoculated as a lawn on agar plates that also 246 included 10 µM of the antibiofilm compounds. Next, L4 stage nematodes were 247 transferred to the plate containing compound-treated PAO1 food sources and survival 248 was monitored over time. Although no significant killing effects were observed for the 249 majority of the compounds tested ( Figure S4 ), compounds I7, I9, I10 and I11 caused a 250 significant reduction in PAO1 virulence after 10 days of feeding on compound-treated 251 bacteria ( Figure 7 ). This increase in nematode survival was comparable to the effect of 252 inactivating the Pel and/or Psl EPS ( Figure 6B ), suggesting that these small molecules 253 demonstrate antivirulence activity for P. aeruginosa due to repression of EPS synthesis. Figure 9A ). RetS was originally described as a transcriptional repressor of pel 289 and psl using microarray analysis [30] . The mechanism of RetS transcriptional control of 290 pel/psl is not understood, given the lack of a known cognate response regulator. We 291 previously reported that the PhoPQ two component system directly represses the retS 292 gene, which may account for the robust biofilm phenotype under the PhoPQ-inducing 293 conditions of growth in limiting Mg 2+ [4] . Repressing the biofilm inhibitor RetS, may lead 294 to increased biofilm through either transcriptional or post-transcriptional control of 295 Pel/Psl. 296 A central feature of the Gac/Rsm pathway is that when biofilm production is 297 promoted, the type III secretion system (T3SS) is repressed [30] . To determine if these 298 antibiofilm compounds potentially act on the Gac/Rsm pathway, we monitored the 299 expression profiles of genes normally repressed under biofilm promoting conditions of 300 limiting Mg 2+ , which includes the retS sensor and the exoT T3SS effector [4, 30] . 301
Several of the antibiofilm compounds caused the induction of retS biofilm 302 repressor and exoT, along with the simultaneous repression of pel ( Figure 9B ), which is 303 the opposite pattern of expression in the biofilm mode of growth. By reversing the 304 expression of genes controlled by the Gac/Rsm pathway, the compounds identified in 305 this study may act somewhere in this regulatory pathway. Some compounds were 306 ineffective in reducing biofilms formed by the retS mutant (I10, I11), suggesting that 307
RetS may be a possible drug target in these cases. However, given the large number of 308 potential protein targets ( Figure 9A ), further work is needed to confirm their possible 309 mechanism of action. 310 311 Conclusion 312 Antivirulence compounds have been described for P. aeruginosa that target the 313 quorum sensing Las, Rhl and Pqs systems [48] . Here we describe the P. aeruginosa 314 EPS biosynthesis genes as a new target for the identification of antivirulence 315 compounds. Biofilm formation is an important focus for new antimicrobials given the 316 universal and conserved process of forming a biofilm, and the diverse protective 317 advantages of cells enmeshed in an extracellular matrix. We identified compounds that 318 repress the expression of the pel and psl EPS genes in P. aeruginosa and hypothesized 319 that this effect would lead to biofilm defective phenotypes. Next we illustrated that EPS 320 production is required for P. aeruginosa virulence in nematode infection ( Figure 6 ), and 321 4 of the 13 pel/psl inhibitors reduced the virulence of PAO1 in the slow killing infection 322 model for C. elegans (Figure 7) . Further, by reducing EPS synthesis and biofilm 323 formation (Figure 3) , the antibiofilm molecules also demonstrated synergistic activity 324 when combined with antibiotic treatment (Figure 8 ). The antibiotic synergies were seen 325 across multiple antibiotic classes, including antibiotics previously shown to be affected 326 by the production of Pel/Psl EPS [8, 15, 17] . 327
Future work will focus on identifying the mechanism of action of the molecules 328 found in this study. Some of the compounds appear to act on the Gac/Rsm pathway, as 329 they reverse the pattern of target gene expression. We used the biofilm promoting 330 conditions of growth in limiting Mg 2+ concentration, which increases EPS production [4] (Table S2 ). In support of our findings, choline 338 analogs have been previously identified as antibiofilm agents against P. aeruginosa 339 ImageJ processing and analysis in Java. 401 402 C. elegans nematode infection models. The nematode feeding preference and slow 403 killing assays were performed as previously described [39] . Briefly, for the feeding 404 preference assay, 20 L4 stage hermaphrodite nematodes were transferred to a slow 405 killing (SK) assay plate containing a pre-grown grid of 45 wild type colonies and 3 406 internal spots of the mutant strains to be tested (6x8 colonies). The plates were 407 incubated at 25 o C and observed twice a day until the disappearance of the initial 408 bacterial colonies. For the slow killing assay, 30 L4 stage nematodes were transferred 409 to a SK plate containing individual pre-grown PAO1 lawns of bacteria to be tested. 410
Nematode survival was determined throughout 10 days by direct observation under a 411 dissecting microscope. 25 µg/ml of 5-fluoro-2'-deoxyuridine (FUdR) was added to SK 412 plates on the slow killing assay for the prevention of offspring development. All 413 compounds were added at 10 µM in the SK agar before bacterial growth. For both in 414 vivo assays, E. coli strain OP50 was used as a positive control to demonstrate preferred 415 feeding behavior and reduced virulence for the nematodes. Nematodes were cultivated 416 on nematode growth medium (NGM) plates containing a lawn of OP50 as food source. 
C. elegans infection models. (A)
The feeding preference assay indicates that the pel/psl double mutant is a preferred food source and was eaten to completion before PAO1. Test strains were embedded in triplicate spots (red box) within a grid of 6x8 positions of wild type PAO1, n=3. The E. coli OP50 strain was used as a positive control of preferred food source known to have reduced virulence (see figure S3 ). 
